Drug Shortage Report for SANDOZ QUETIAPINE
Report ID | 110041 |
Drug Identification Number | 02313995 |
Brand name | SANDOZ QUETIAPINE |
Common or Proper name | QUETIAPINE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-02-27 |
Estimated end date | Unknown |
Actual end date | 2020-01-31 |
Shortage status | Avoided shortage |
Updated date | 2023-11-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-11-17 | French | Compare |
v9 | 2023-11-17 | English | Compare |
v8 | 2020-04-27 | French | Compare |
v7 | 2020-04-27 | English | Compare |
v6 | 2020-04-15 | French | Compare |
v5 | 2020-04-15 | English | Compare |
v4 | 2020-04-07 | French | Compare |
v3 | 2020-04-07 | English | Compare |
v2 | 2020-03-30 | French | Compare |
v1 | 2020-03-30 | English | Compare |
Showing 1 to 10 of 10